|
Market Closed -
Euronext Bruxelles
11:55:00 2026-08-21 am EDT
|
5-day change | 1st Jan Change | ||
| 221.70 EUR | +1.74% |
|
+4.43% | -7.08% |
| Aug. 20 | Cancer vaccines finally garner the spotlight |  |
| Aug. 19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
| Market Cap | 42.27B 49.35B 39.55B 36.2B 67.95B 4,721B 68.84B 467B 182B 2,372B 185B 181B 7,845B | P/E 2026 * |
22.2x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 42.59B 49.72B 39.85B 36.48B 68.46B 4,757B 69.37B 471B 184B 2,390B 187B 183B 7,904B | EV / Sales 2026 * |
4.9x | EV / Sales 2027 * | 4.18x |
| Free-Float |
61.59% | Yield 2026 * |
0.66% | Yield 2027 * | 0.68% |
Last Transcript: UCB
| 1 day | +1.74% | ||
| 1 week | +4.43% | ||
| Current month | -0.54% | ||
| 1 month | -8.88% | ||
| 3 months | -8.39% | ||
| 6 months | -19.70% | ||
| Current year | -7.08% |
| 1 week | 212.2 |  | 221.7 |
| 1 month | 211.6 | | 251.5 |
| Current year | 211.6 | | 289.5 |
| 1 year | 191.2 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 60 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| 1/15/26 | Buy | Director | 500 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.74% | +4.43% | +12.37% | +169.64% | 49.35B | |
| +0.90% | +3.80% | +41.49% | -0.78% | 83.28B | |
| +8.86% | +129.20% | +435.14% | +24.85% | 57.94B | |
| -1.69% | +23.30% | -22.30% | -36.29% | 57.77B | |
| -1.46% | +0.19% | -2.06% | +30.50% | 51.75B | |
| +1.13% | +3.31% | +55.61% | -17.57% | 32.03B | |
| +0.46% | +6.37% | +50.29% | +97.27% | 25.91B | |
| +1.19% | +9.17% | +2.97% | +230.86% | 22.74B | |
| -0.30% | +4.45% | +58.29% | +118.84% | 16.87B | |
| -5.74% | +1.91% | -1.42% | +795.59% | 16.08B | |
| Average | +0.51% | +18.61% | +63.04% | +141.29% | 41.37B | |
| Weighted average by Cap. | +1.16% | +24.08% | +77.34% | +75.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.69B 10.14B 8.13B 7.44B 13.97B 970B 14.15B 96.04B 37.45B 487B 38.08B 37.26B 1,612B | 9.69B 11.31B 9.07B 8.3B 15.58B 1,082B 15.78B 107B 41.77B 544B 42.48B 41.55B 1,798B |
| Net income | 1.93B 2.25B 1.8B 1.65B 3.09B 215B 3.14B 21.28B 8.3B 108B 8.44B 8.26B 357B | 2.33B 2.72B 2.18B 1.99B 3.74B 260B 3.79B 25.73B 10.03B 131B 10.2B 9.98B 432B |
| Net Debt | 321M 375M 301M 275M 516M 35.88B 523M 3.55B 1.38B 18.02B 1.41B 1.38B 59.61B | -1.8B -2.1B -1.68B -1.54B -2.89B -201B -2.93B -19.88B -7.75B -101B -7.88B -7.71B -334B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €221.70 | +1.74% | 253,935 |
| 26-08-20 | €217.90 | +0.05% | 183,496 |
| 26-08-19 | €217.80 | +0.23% | 199,754 |
| 26-08-18 | €217.30 | +0.88% | 164,194 |
| 26-08-17 | €215.40 | +1.46% | 250,813 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Select your edition
All financial news and data tailored to specific country editions
